Skip to content

    Best Agrolife

    BESTAGRO
    Chemicals·8 Aug 2025
    Management Summary

    Best Agrolife reported a strategic shift in Q1 FY26, prioritizing profitability and patented products over early placements, leading to a 26.4% YoY revenue decline to ₹382 crores. Despite this, gross margins improved to 30% and EBITDA margin expanded to 12%. The company saw significant reduction in sales returns and is optimistic about future margin expansion and new product contributions.

    Highlights

    5

    • Gross margin improved to 30% from 24% YoY, reaching ₹111 crores.

    • EBITDA margin expanded by 140 basis points to 12% in Q1 FY26.

    • PAT margin increased to 5% from 4% in Q1 FY25, with PAT stable at ₹20 crores.

    • Patented products' contribution to brand sales increased to 45% from 29% last year.

    • Actual sales returns significantly reduced to ₹13 crores in Q1 FY26, compared to ₹35-40 crores in Q1 FY25.

    Concerns

    2

    • Revenue declined by 26.4% YoY to ₹382 crores in Q1 FY26 due to a strategic shift in sales policy.

    • EBITDA decreased to ₹46 crores in Q1 FY26 from ₹55 crores in Q1 FY25.

    What Changed2

    vs Q2 FY26

    Guidance items6 → 7 (+1)Risks discussed4 → 5 (+1)

    Key financials

    Single quarter

    10 metrics
    1. 01Revenue₹382 Cr-26.4%YoY
    2. 02Gross Margin₹111 Cr
    3. 03Gross Margin Percentage30%
    4. 04EBITDA₹46 Cr
    5. 05EBITDA Margin12%

    Capital allocation

    1
    high confidence
    CategoryHeadline
    Capex

    ₹90 crores

    ₹60 crores funded by a financer

    Guidance & targets

    7
    CategoryTargetPriority
    Revenue
    Annual Revenue
    ₹1,600-1,700 crores
    		High
    Profitability
    Annual EBITDA Margin
    Exceed 15% plus
    		High
    Profitability
    Q2 EBITDA Margin
    Much higher than 17%, 18%
    		High
    Sales
    Annual Sales Return Percentage
    Not more than 10% to 12%
    		High
    Operating Expenses
    Annual OPEX Reduction
    ₹30-40 crores
    		High
    New Product Launches
    New Product Launch
    Bestman
    		High
    New Product Launches
    New Product Launch
    One more product
    		High

    Q2 Revenue Performance

    next quarter
    CurrentQ1 FY26 revenue down 26.4% YoY to ₹382 crores
    TargetRevenue pickup in Q2, aligned with seasonal trends

    Why it matters

    To verify if the strategic shift in sales policy (deferring placements) leads to the expected revenue recovery in Q2.

    Looking ahead, we anticipate a revenue pickup in Q2, aligned with seasonal trends and a delayed carry swing.

    How to verify

    key_financials.metrics[label='Revenue']

    Risks & concerns

    5
    RiskSeverity

    Monsoon variability impacting showing activity

    Mixed monsoon season with normal to above normal rainfall in most parts, but variability in certain regions impacted showing activity. — Management acknowledged

    medium

    Lower Q1 revenue due to strategic shift in sales policy

    Strategic decision to implement revised sales policies, reducing early product placement to focus on in-season sales, resulted in lower Q1 revenue. — Management acknowledged

    medium

    Delay in season, especially in the South

    A considerable delay in the season, particularly in South India, impacted Q1 sales, but sales are expected to shift to Q2 and Q3. — Management acknowledged

    low

    Chilli market issues and reduced cotton acreage

    Chilli prices have issues and cotton acreage is less, but management states it does not significantly impact their overall business due to their market share and market scope. — Analyst downplayed

    low

    Longer registration time for international patented products

    Registration for new molecules and formulations in international markets takes longer due to extensive field trials and regulatory processes. — Management acknowledged

    medium

    Q&A highlights

    8

    “If we talk about the technical sales, their margin will be very less. So, we are now moving towards a profitable organization rather than keeping only the sales revenues.”

    Clarifies the company's strategic shift from volume-driven technical sales to higher-margin branded products, explaining the Q1 revenue dip.

    asked by Hemant

    2 min read6 chapters

    Detailed Narrative

    01

    Strategic Shift Towards Profitability and Patented Products

    Best Agrolife has implemented a strategic shift in its sales policy, moving from early product placement to focusing on in-season sales and patented molecules. This aims to enhance profitability, reduce excess inventory, and lower sales returns. This strategic decision led to a 26.4% YoY decline in Q1 FY26 revenue to ₹382 crores from ₹519 crores in Q1 FY25. The company believes this is a critical step towards a more sustainable business model, with benefits expected in subsequent quarters.

    02

    Improved Margins Despite Revenue Decline

    Despite the year-on-year dip in revenue, the company's profitability improved significantly due to a richer product mix and disciplined pricing. Gross margins for Q1 FY26 stood at ₹111 crores, with the margin percentage improving to 30% from 24% in Q1 FY25. EBITDA for the quarter was ₹46 crores, down from ₹55 crores YoY, but the EBITDA margin expanded by 140 basis points to 12%. Profit after tax remained stable at ₹20 crores, with the PAT margin increasing to 5% from 4% in Q1 FY25.

    03

    New Product Launches and Patent Portfolio Expansion

    Best Agrolife successfully launched new patented products like 'Shot Down' (a soybean herbicide) and 'Bestman,' which are performing well in their debut season. The company secured two new patents in Q1 FY26 for novel insecticide-fungicide combinations, offering broad-spectrum pest and disease control. Additionally, new FIM registrations were obtained for 'Cubax Power Extra' and 'Trishanku,' targeting various pests and crops, reinforcing the focus on innovation-led growth.

    04

    Enhanced Inventory Management and Reduced Sales Returns

    The revised sales policies have led to a significant reduction in sales returns, contributing to improved inventory hygiene and enhanced profitability. In Q1 FY26, actual sales returns were only ₹13 crores, a substantial decrease from ₹35-40 crores in Q1 FY25. The company made a conservative provision of ₹50 crores for sales returns in Q1, anticipating a potential reversal if actual returns remain low, which would further boost profitability.

    05

    International Business Expansion and Global Patents

    The company is actively expanding its international footprint, having completed assignments in an African nation and initiating registration processes for patented products in Sri Lanka and nano-urea in Australia and Mauritius. Global patent filings were made in key jurisdictions such as the US, EU, UAE, Brazil, Vietnam, Egypt, and Indonesia. This strategy focuses on innovation-led international growth, leveraging the company's technical manufacturing capabilities for global markets.

    06

    FY26 Capex Plans and Future Outlook

    Best Agrolife plans a CAPEX of ₹90 crores for FY26, with ₹60 crores funded by a financer, for an additional plant at its Gajraula facility. This plant is expected to be completed in one year, with benefits accruing from FY27. The company targets an annual revenue of ₹1,600-1,700 crores for FY26-27 with an EBITDA margin exceeding 15% plus, driven by product innovation, margin improvement, and operational efficiency.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.